Tobacco Cessation in Public Housing
Comprehensive Tobacco Cessation for Residents of Baltimore City Public Housing
2 other identifiers
interventional
18
1 country
1
Brief Summary
The inequity in cessation resources is at forefront in the recently enacted nationwide smoking ban in public housing facilities. The critical component lacking from the federal decree was a practical smoking cessation strategy to address the real-world needs of active smokers who maintain cigarette usage. The investigator's proposal is ideally situated for this contemporary moment when low-income smokers in public housing are signing leases describing the potential for smoking-related evictions and thus at least contemplating smoking modification. The investigator's project is centered around the residents of Baltimore City Public Housing which is among the larger-sized U.S. public housing agencies. Using a human-centered design (HCD) approach, the investigators are refining and testing a community-centric cessation strategy defined by two core elements: a) durable and jointly linked community/hospital infrastructure systems (remote cessation specialist staffing and drug supplies) and strong on-site (public housing) residential leadership commitment to cessation improvement. These dual features, along with adaptable elements that can be modified to a variety of local/national housing settings, defines how the investigator's project will overcome the implementation gaps defining failed smoking cessation efforts in lower-income settings. The objective of this project is to test the feasibility of the intervention package among local housing contextual factors that could impact both the acceptability and adoptability of the investigator's project. Using a collection of formative and implementation evaluation measures, the investigator's academic-community partnership project is well positioned to create an adaptable and customizable intervention that can be scaled in similar housing populations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2021
CompletedFirst Posted
Study publicly available on registry
May 17, 2021
CompletedStudy Start
First participant enrolled
April 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 18, 2024
CompletedResults Posted
Study results publicly available
January 22, 2026
CompletedJanuary 22, 2026
January 1, 2026
7 months
May 12, 2021
December 11, 2025
January 5, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Nicotine Dependence (Short Form 8a) Score
This outcome measures assesses cravings or withdrawal that occurs upon brief cessation of smoking, smoking temptations, compulsive use, and tolerance. The scores range from 8 - 40. The lower end of the range indicates no nicotine dependence and the upper end of the range correlates with a high degree of dependence.
Baseline, 4 weeks
Secondary Outcomes (5)
Change in PROMIS Coping Expectancies (Short Form 4a) Score
Baseline, 4 weeks
Change in PROMIS Emotional and Sensory Expectancies (Short Form 6a) Score
Baseline, 4 weeks
Change in PROMIS Health Expectancies (Short Form 6a) Score
Baseline, 4 weeks
Change in PROMIS Psychosocial Expectancies (Short Form 6a) Score
Baseline, 4 weeks
Change in PROMIS Social Motivations (Short Form 4a) Score
Baseline, 4 weeks
Study Arms (1)
Cessation intervention
EXPERIMENTALParticipants will undergo pre-/post-comparisons of a personalized, remote smoking cessation intervention composed of two main elements: a) prescription and monitoring of nicotine (e.g., replacement therapy) and/or non-nicotine pharmacotherapies (e.g., varenicline) and b) cessation-centered motivational messaging.
Interventions
1. Pharmacotherapy selection, prescription and monitoring of up to two types of cessation pharmacotherapies: Nicotine replacement therapy (gum, lozenge and transdermal patch) and non-nicotine replacement therapy (varenicline). 2. Remote video-conferencing and mobile phone-based, personalized motivational messaging
Eligibility Criteria
You may qualify if:
- ≥18 years of age to 99 years old
- Self-reported smoker with either daily or weekly cigarette use, as well as expressed desire to reduce or quit smoking
- Proof of residence at Douglass or Brooklyn Homes through verbal acknowledgement by the Service Coordinators at each of the public housing sites.
- Working cell phone with ability to text for the duration of the study
- Active health insurance (for pharmacotherapy billing)
You may not qualify if:
- Pregnant - women will verbally acknowledge that they are not pregnant
- Breastfeeding - women who are verbally acknowledge they are breastfeeding will be excluded from the study.
- Ongoing participation in a tobacco cessation program or related tobacco intervention study
- Unable to verbally state that they are willing to reduce or quit smoking upon recruitment and screening
- Adults lacking capacity to consent
- Non-English speakers
- Self-reported usage of only non-combustible tobacco products, such as smokeless tobacco or Electronic Nicotine Delivery Devices (ENDS).
- Anticipated relocation outside of Douglass or Brooklyn Homes prior to the final study visit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Creative Alternative
Baltimore, Maryland, 21224, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Panagis Galiatsatos, MD, MHS
- Organization
- Johns Hopkins University School of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Panagis Galiatsatos
Johns Hopkins University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2021
First Posted
May 17, 2021
Study Start
April 3, 2024
Primary Completion
October 18, 2024
Study Completion
October 18, 2024
Last Updated
January 22, 2026
Results First Posted
January 22, 2026
Record last verified: 2026-01